← Leaderboards
Ph.d. Dabt, David McCormick
Iit Research Institute
$2,029,696
Attributed
$2,029,696
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2016–18$2M$1.5M$1M$500K$0
'16
'17
'18
Funding mix
By agency
NIH$2,029,696 · 1
By mechanism
N01$2,029,696 · 1
Top collaborators
No co-investigators on record.
Most similar at Iit Research Institute
Same institution · by research overlap
- David McCormick$23,114,492
Others in their field
Top investigators on “Biological Availability”
- David Heimbrook · Leidos Biomedical Research, Inc.$382,069,903
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$225,482,153
- Christopher McKay · Battelle Memorial Institute$156,659,640
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- David R. Weir · University Of Michigan At Ann Arbor$124,409,862
- Jeffrey P Krischer · University Of South Florida$108,549,354
Research focus
Biological AvailabilityToxicologyOralRattusDoseFormulationIn VivoToxic EffectPre-ClinicalBody Surface AreaCaviaDelayed HypersensitivityCellsCervical Intraepithelial NeoplasiaCanis FamiliarisAnti-InflammatoryDermalBaseCruciferous VegetableDependenceCyp2d6 GeneCyp3a4 GeneDiindolylmethaneContractor
Grant awards (4)
PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS$60,976
N01 · FY2018 · CA · contact PI
PRECLINICAL PREVENT TOXICOLOGY AND PHARMACOLOGY$174,815
N01 · FY2017 · CA · contact PI
IGF::OT::IGF PRECLINICAL PREVENT TOXICOLOGY AND PHARMACOLOGY$1,531,900
N01 · FY2016 · CA · contact PI
IGF::OT::IGF HHSN2612015000241 PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS$262,005
N01 · FY2016 · CA · contact PI